Communiqués Cibus, Inc. Nasdaq

Actions

CLXT

US17166A1016

Temps réel estimé Cboe BZX Autres places de cotation 16:54:03 28/06/2024			Varia. 5j.	Varia. 1 janv.
9,87 ^USD	+4,00%		-1,66%	-51,68%

26/06	Cibus, Inc. élargit sa couverture de la propriété intellectuelle pour l'édition de gènes et les caractères des plantes	CI
30/05	Le programme de résistance à la moisissure blanche (sclérotinia) Cibus ? Le programme de résistance à la moisissure blanche (Sclerotinia) confirme une étape importante pour les modifications génétiques de la prochaine génération dans le canola.	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding	15/05	AQ
Cibus: Q1 Earnings Snapshot	09/05	AQ
Cibus Reports First Quarter Financial Results and Provides Business Update	09/05	AQ
CALYXTPAR : UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION - Form 8-K	21/03	PU
Cibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024	19/03	AQ
Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call	07/03	AQ
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US	26/02	AQ
Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells	09/01	AQ
Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus	30/11	AQ
CALYXTPAR : UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION - Form 8-K	09/11	PU
Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update	09/11	AQ
Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call	02/11	AQ
CALYXTPAR : UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION - Form 8-K	25/10/23	PU
Jim Collins to Join Cibus Board of Directors	18/09/23	AQ
Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference	05/09/23	AQ
Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update	09/08/23	AQ
Steve Berreth Appointed as General Counsel and Corporate Secretary	03/08/23	AQ
Cibus to Report Second Quarter 2023 Financial Results on August 10, 2023 and Host Conference Call	03/08/23	AQ
Cibus to Present at the Canaccord 43rd Annual Growth Conference	02/08/23	AQ
Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production	12/07/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cibus, Inc. Nasdaq

Actions

CLXT

US17166A1016

Communiqués

Filtres